Zaltoprofen inhibits bradykinin-mediated enhancement of glutamate receptor activity in substantia gelatinosa neurons

Anesthesia and Analgesia

Volumn 113, Issue 2, 2011, Pages 412-416

  Kohno, Tatsuro ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BRADYKININ; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; GLUTAMATE RECEPTOR; IBUPROFEN; PROSTAGLANDIN E2; PROTEIN KINASE C ACTIVATOR; ZALTOPROFEN;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; MOUSE; NERVE CELL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SPINAL CORD DORSAL HORN; SUBSTANTIA GELATINOSA; TISSUE SLICE; TRANSPORT KINETICS; WHOLE CELL;

EID: 79961027878     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31821c693c     Document Type: Article

References (21)

1. Kameyama T, Nabeshima T, Yamada S, Sato M. Analgesic and antiinflammatory effects of 2-(10,11-dihydro-10-oxo-dibenzo [b,f]thiepin-2-yl)propionic acid in rat and mouse. Arzneimittelforschung 1987;37:19-26 (Pubitemid 17219600)
2. Tsurumi K, Kyuki K, Niwa M, Kokuba S, Fujimura H. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10- oxodibenzo[b,f]thiepin-2-yl)propionic acid. 1st communication: Inhibitory effects of rat paw edema. Arzneimittelforschung 1986;36:1796-800 (Pubitemid 17204421)
3. Kawai S, Nishida S, Kato M, Furumaya Y, Okamoto R, Koshino T, Mizushima Y. Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. Eur J Pharmacol 1998;347:87-94 (Pubitemid 28238090)
4. Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 1996; 390:165-9 (Pubitemid 26281193)
5. Yang LC, Marsala M, Yaksh TL. Characterization of time course of spinal amino acids, citrulline and PGE2 release after carrageenan/kaolin-induced knee joint inflammation: A chronic microdialysis study. Pain 1996;67:345-54 (Pubitemid 26375350)
6. Uda R, Horiguchi S, Ito S, Hyodo M, Hayaishi O. Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice. Brain Res 1990;510:26-32 (Pubitemid 20060798)
7. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992;263:136-46
8. Chapman V, Dickenson AH. The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat. Eur J Pharmacol 1992;219:427-33
9. Matsumoto M, Inoue M, Ueda H. NSAID zaltoprofen possesses novel anti-nociceptive mechanism through blockage of B2-type bradykinin receptor in nerve endings. Neurosci Lett 2006;397:249-53
10. Muratani T, Doi Y, Nishimura W, Nishizawa M, Minami T, Ito S. Preemptive analgesia by zaltoprofen that inhibits bradykinin action and cyclooxygenase in a post-operative pain model. Neurosci Res 2005;51:427-33 (Pubitemid 40299330)
11. Scholz J, Woolf CJ. Can we conquer pain? Nat Neurosci 2002;5(Suppl):1062-7 (Pubitemid 35247200)
12. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol Rev 1992; 44:1-80
13. Dray A. Kinins and their receptors in hyperalgesia. Can J Physiol Pharmacol 1997;75:704-12 (Pubitemid 27458660)
14. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2- mediated inhibition. Nature 2001;411:957-62 (Pubitemid 32601493)
15. Hirate K, Uchida A, Ogawa Y, Arai T, Yoda K. Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinininduced pain responses without blocking bradykinin receptors. Neurosci Res 2006;54:288-94 (Pubitemid 43374447)
16. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, Kim SH, Lee MG, Choi YH, Kim J, Haber NA, Reichling DB, Khasar S, Levine JD, Oh U. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 2002;99:10150-5 (Pubitemid 34831187)
17. Tang HB, Inoue A, Oshita K, Hirate K, Nakata Y. Zaltoprofen inhibits bradykinin-induced responses by blocking the activation of second messenger signaling cascades in rat dorsal root ganglion cells. Neuropharmacology 2005;48:1035-42 (Pubitemid 40602611)
18. Vanegas H, Schaible HG. Prostaglandins and cyclooxygenases in the spinal cord. Prog Neurobiol 2001;64:327-63
19. Wang H, Kohno T, Amaya F, Brenner GJ, Ito N, Allchorne A, Ji RR, Woolf CJ. Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission. J Neurosci 2005;25:7986-92 (Pubitemid 41254401)
20. Kohno T, Wang H, Amaya F, Brenner GJ, Cheng JK, Ji RR, Woolf CJ. Bradykinin enhances AMPA and NMDA receptor activity in spinal cord dorsal horn neurons by activating multiple kinases to produce pain hypersensitivity. J Neurosci 2008;28:4533-40
21. Kohno T, Wakai A, Ataka T, Ikoma M, Yamakura T, Baba H. Actions of midazolam on excitatory transmission in dorsal horn neurons of adult rat spinal cord. Anesthesiology 2006;104:338-43